Resource

HIV pre-exposure prophylaxis for adolescents and young adults

11 August 2017 by SHARE Administrator
Resource details

This review describes the evidence for HIV preexposure prophylaxis (PrEP) with daily combined tenofovir disoproxil fumarate and emtricitabine for adolescents and young adults. Current recommendations are described, as are the unique medical, socioeconomic, and legal considerations regarding the use of PrEP for youth.